X4 Pharmaceuticals Inc
NASDAQ:XFOR

Watchlist Manager
X4 Pharmaceuticals Inc Logo
X4 Pharmaceuticals Inc
NASDAQ:XFOR
Watchlist
Price: 1.49 USD 2.05% Market Closed
Market Cap: 8.8m USD

Wall Street
Price Targets

XFOR Price Targets Summary
X4 Pharmaceuticals Inc

There are no price targets for XFOR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
X4 Pharmaceuticals Inc Competitors:
Price Targets
2142
Hbm Holdings Ltd
31% Upside
IMMX
Immix Biopharma Inc
199% Upside
002007
Hualan Biological Engineering Inc
18% Upside
TECX
AVROBIO Inc
267% Upside
ZEAL
Zealand Pharma A/S
156% Upside
1875
TOT BIOPHARM International Co Ltd
3% Upside
397030
AprilBio Co Ltd
70% Upside
ASND
Ascendis Pharma A/S
24% Upside

Revenue
Forecast

Revenue Estimate
X4 Pharmaceuticals Inc

The compound annual growth rate of X4 Pharmaceuticals Inc's revenue for the next 3 years is 255%.

N/A
Past Growth
255%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
X4 Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
X4 Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XFOR's stock price target?
Not Available

XFOR doesn't have any price targets made by Wall Street professionals.

What is X4 Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
255%

The compound annual growth rate of X4 Pharmaceuticals Inc's revenue for the next 3 years is 255%.

Back to Top